SMI
11.934,17
PKT
+152,43
PKT
+1,29
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.12.17 | UBS buy | Goldman Sachs Group Inc. | |
| 05.12.17 | UBS Neutral | Goldman Sachs Group Inc. | |
| 04.12.17 | Givaudan Hold | Deutsche Bank AG | |
| 04.12.17 | ABB (Asea Brown Boveri) buy | Deutsche Bank AG | |
| 01.12.17 | Roche Equal-Weight | Morgan Stanley | |
| 01.12.17 | Novartis overweight | Morgan Stanley | |
| 01.12.17 | UBS kaufen | Independent Research GmbH | |
| 01.12.17 | UBS buy | Citigroup Corp. | |
| 01.12.17 | Roche Outperform | Bernstein Research | |
| 01.12.17 | Zurich Insurance Hold | Kepler Cheuvreux | |
| 01.12.17 | UBS Outperform | RBC Capital Markets | |
| 01.12.17 | UBS buy | Goldman Sachs Group Inc. | |
| 01.12.17 | UBS overweight | JP Morgan Chase & Co. | |
| 01.12.17 | UBS buy | UBS AG | |
| 30.11.17 | UBS overweight | JP Morgan Chase & Co. | |
| 30.11.17 | UBS buy | UBS AG | |
| 30.11.17 | UBS buy | Deutsche Bank AG | |
| 30.11.17 | Swiss Re Sell | UBS AG | |
| 29.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.11.17 | UBS buy | Baader Bank | |
| 29.11.17 | Holcim Outperform | Bernstein Research | |
| 29.11.17 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 28.11.17 | Swiss Re Hold | Jefferies & Company Inc. | |
| 27.11.17 | UBS buy | Goldman Sachs Group Inc. | |
| 27.11.17 | Zurich Insurance Neutral | JP Morgan Chase & Co. | |
| 24.11.17 | Givaudan Neutral | UBS AG | |
| 24.11.17 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.11.17 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 22.11.17 | Swiss Re Hold | Société Générale Group S.A. (SG) | |
| 22.11.17 | Nestlé buy | Kepler Cheuvreux | |
| 22.11.17 | UBS Hold | Deutsche Bank AG | |
| 22.11.17 | UBS buy | Deutsche Bank AG | |
| 22.11.17 | Swiss Re buy | Baader Bank | |
| 21.11.17 | Roche buy | Baader Bank | |
| 21.11.17 | Nestlé overweight | JP Morgan Chase & Co. | |
| 21.11.17 | Roche Hold | Deutsche Bank AG | |
| 21.11.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.11.17 | Roche Reduce | HSBC | |
| 21.11.17 | UBS buy | Goldman Sachs Group Inc. | |
| 21.11.17 | UBS Neutral | Goldman Sachs Group Inc. |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.